Legal Opinion
Amgen Inc. v. Hospira, Inc.
Court of Appeals for the Federal Circuit
Decided August 10, 2017No. 2016-2179PublishedCited by 5 opinions
1Opinion of the Court
DYK, Circuit Judge.
Amgen Inc. (“Amgen”) appeals an order of the United States District Court for the District of Délaware denying Amgen’s motion to compel discovery from Hospira, Inc. (“Hospira”) in a patent infringement case governed by the Biologies Price Competition and Innovation Act of 2009 (“BPCIA”), Pub. L. No. 111-148, 124 Stat. 119, 804 (2010) (amending 42 U.S.C. § 262). Amgen alternatively seeks a writ of mandamus ordering the court to- compel discovery.
Because we lack jurisdiction over the district court’s order under the collateral order doctrine and find that Amgen fails to…
2Cases cited18 opinions
- Cohen v. Beneficial Industrial Loan Corp.Supreme Court of the United States · 1949
- Mitchell v. ForsythSupreme Court of the United States · 1985
- Coopers & Lybrand v. LivesaySupreme Court of the United States · 1978
- Catlin v. United StatesSupreme Court of the United States · 1945
- Puerto Rico Aqueduct and Sewer Authority v. Metcalf & Eddy, Inc.Supreme Court of the United States · 1993
13 more not listed; retrieve them via the Exa API.
3Cited by5 opinions
- Waymo LLC v. Uber Technologies, Inc.Court of Appeals for the Federal Circuit · 2017
- Modern Font Applications LLC v. Alaska AirlinesCourt of Appeals for the Federal Circuit · 2022
- Board of Regents v. Boston Scientific CorporationCourt of Appeals for the Federal Circuit · 2019
- Friedman v. BacaDistrict Court, D. Nevada · 2019
- Strohmeyer v. BelangerDistrict Court, D. Nevada · 2019